Fundz

Altimmune Appoints Richard Menziuso as Vice President, Global Controller

PUBLIC · ALTSep 29, 2026
New to company · from Centessa Pharmaceuticals“He previously served as Vice President, Corporate Controller at Centessa Pharmaceuticals.”

Position

Principal

Company

Altimmune

Richard Menziuso
rmenziuso@altimmune.com
MorristownBiotechnologyHealth CareTherapeuticsBiopharmaresearch

Description

On September 24, 2026, Altimmune, Inc. appointed Richard Menziuso as its Vice President, Global Controller, and Principal Accounting Officer. This appointment is effective as of September 29, 2026

Quick answer

Altimmune Appoints Richard Menziuso as Vice President, Global Controller (September 29, 2026). Altimmune is based in Morristown, New Jersey, United States.

Who is the new Principal at Altimmune?
Altimmune named Richard Menziuso Principal, announced September 29, 2026.
What did Altimmune announce on September 29, 2026?
On September 24, 2026, Altimmune, Inc. appointed Richard Menziuso as its Vice President, Global Controller, and Principal Accounting Officer.
Where did Richard Menziuso work before joining Altimmune?
Richard Menziuso joins from Centessa Pharmaceuticals.
What does Altimmune do?
Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases.
Where is Altimmune based?
Altimmune is based in Morristown, New Jersey, United States.
Which similar companies made leadership changes around the same time?
Cantargia AB (October 26, 2026), Aquestive Therapeutics, Inc. (September 29, 2026), Apimeds Pharmaceuticals US (October 1, 2026) and Os Therapies (October 1, 2026) also announced leadership changes within 45 days of Altimmune.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Altimmune, and when

A new leader at Altimmune brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Altimmune raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Altimmune, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Altimmune. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Altimmune

Location

Morristown, New Jersey, United States

About

Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alcohol Use Disorder (AUD), Alcohol-associated Liver Disease (ALD) and obesity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Altimmune changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Karen
Likely contact at this company
••••••••@••••••••

See Karen's verified email →

Siavoche
Likely contact at this company
••••••••@••••••••

See Siavoche's verified email →

Sarah
Likely contact at this company
••••••••@••••••••

See Sarah's verified email →

Greg
Likely contact at this company
••••••••@••••••••

See Greg's verified email →

Richard
Likely contact at this company
••••••••@••••••••

See Richard's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Altimmune's next move

Learn about Strategic plan

Altimmune changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.